Skip to main content

Insulet Corporation statistics

  • PODD · Nasdaq
  • Medical devices
  • Health Care Equipment
  • S&P 500
$152.48+2.14%Close 13 Nov 2026

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

Enterprise value$10.96B
EV / EBITDA15.80
EV / sales3.44

Share price

Latest close$152.48
Day's change+2.1%
52-week high$354.88
52-week low$126.40
From 52-week high−57.0%
Return · 1 month+8.1%
Return · 3 months+3.8%
Return · year to date−46.4%
Return · 1 year−54.7%
Beta · 1 year against the S&P 5000.44
50-day average$142.14
200-day average$172.70
RSI 1455.7
Average volume · 20 sessions1.4M

Margins and returns

For fiscal 2025, as filed.

Gross margin71.6%
Operating margin17.5%
Net margin9.1%
Free cash flow margin13.9%
Return on equity18.1%
Return on assets11.0%
Return on invested capital19.5%
Return on capital employed18.7%
Stock-based compensation / revenue2.3%

Financial position

At the end of fiscal 2025.

Cash and equivalents$716.1M
Total debt$1.00B
Net debt$285.0M
Current ratio2.81
Debt / equity0.66
Net debt / EBITDA0.51
Interest coverage7.98

Shares and dividends

For fiscal 2025, as filed.

Diluted shares71.9M
Net share repurchases$40.60M

Taxes

For fiscal 2025, as filed.

Income tax expense$92.40M
Effective tax rate27.2%

PODD in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.